博雅生物：截至目前，公司共计拥有21个单采血浆站

Core Viewpoint - The company maintains an open and proactive attitude towards opportunities that align with its long-term development plans, focusing on strengthening its core blood products business and enhancing operational performance through both organic and external growth strategies [2] Company Summary - As of now, the company operates a total of 21 plasma collection stations, including 4 under the Green Cross brand [2] - In the first half of 2025, the raw plasma collection volume reached 320.39 tons, representing a year-on-year increase of 7.2%, which is higher than the industry average growth rate [2] Industry Summary - The company is committed to continuous efforts in both internal and external development to elevate its operational performance to new heights [2]